Cargando…

Damage in hidradenitis suppurativa: receiving the deserved attention

Linked Article: Fritsche et al. Br J Dermatol 2022; 187:288–294.

Detalles Bibliográficos
Autores principales:	Aarts, Pim, van der Zee, Hessel H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541686/ https://www.ncbi.nlm.nih.gov/pubmed/35508388 http://dx.doi.org/10.1111/bjd.21611

Ejemplares similares

Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa
por: Aarts, Pim, et al.
Publicado: (2021)

Validity and Reliability of Two Digital Wound Measurement Tools after Surgery in Patients with Hidradenitis Suppurativa
por: Aarts, Pim, et al.
Publicado: (2023)

Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study
por: Aarts, Pim, et al.
Publicado: (2023)

Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study
por: Bouwman, Klasiena, et al.
Publicado: (2022)

Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study
por: Vossen, Allard R. J. V., et al.
Publicado: (2017)

Should Patients with Hidradenitis Suppurativa Undergo LASIK?
por: Rosen, David B., et al.
Publicado: (2019)

Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model
por: Vossen, Allard R. J. V., et al.
Publicado: (2018)

Incidence of self‐reported hidradenitis suppurativa – a commentary
por: Micali, G.
Publicado: (2022)

Venous thromboembolism deserves your attention
por: Marc Samama, Charles
Publicado: (2001)

Novel cytokine and chemokine markers of hidradenitis suppurativa reflect chronic inflammation and itch
por: Vossen, Allard R. J. V., et al.
Publicado: (2018)

Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?
por: van Straalen, K. R., et al.
Publicado: (2022)

Management of mild hidradenitis suppurativa: our greatest challenge yet
por: van der Zee, H.H., et al.
Publicado: (2021)

The prevalence of hidradenitis suppurativa outside the hospital setting: the impact of the undiagnosed
por: Kearney, Niamh, et al.
Publicado: (2022)

A growing family of outcome measurement proposals for hidradenitis suppurativa
por: Emtestam, L., et al.
Publicado: (2021)

Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study
por: Willems, Damon, et al.
Publicado: (2021)

Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe
por: Willems, Damon, et al.
Publicado: (2023)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Compartmentalized Cytokine Responses in Hidradenitis Suppurativa
por: Kanni, Theodora, et al.
Publicado: (2015)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers
por: Vossen, A.R.J.V., et al.
Publicado: (2018)

Surgical Treatment in Hidradenitis Suppurativa
por: Shukla, Ratnakar, et al.
Publicado: (2022)

Surgical management of hidradenitis suppurativa
por: Gierek, Marcin, et al.
Publicado: (2022)

Certolizumab to treat hidradenitis suppurativa
por: Shadid, Asem, et al.
Publicado: (2022)

Surgical Management of Hidradenitis Suppurativa
por: Menderes, Adnan, et al.
Publicado: (2010)

Hidradenitis Suppurativa: Inside and Out
por: Patil, Sharmila, et al.
Publicado: (2018)

Multimodal management of hidradenitis suppurativa
por: Jemec, Gregor B.E.
Publicado: (2020)

Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020)

Secondary prevention of hidradenitis suppurativa
por: Kurzen, Hjalmar, et al.
Publicado: (2019)

Facklamia hominis in hidradenitis suppurativa
por: Basal, Yasmeen, et al.
Publicado: (2021)

Management of Severe Hidradenitis Suppurativa
por: Katzman, Ju Hee, et al.
Publicado: (2021)

Hydroxychloroquine for the treatment of hidradenitis suppurativa
por: Brant, Elena Gonzalez, et al.
Publicado: (2023)

Dietary Factors and Hidradenitis Suppurativa
por: Shen, Alan S., et al.
Publicado: (2023)

Postoperative Quality of Life in Patients with Hidradenitis Suppurativa Utilizing the Hidradenitis Suppurativa Burden of Disease Tool
por: Guart, Jiddu A, et al.
Publicado: (2021)

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa
por: Gibson, Ruby S., et al.
Publicado: (2022)

Hidradenitis suppurativa: an update on connecting the tracts
por: Smith, Mallory K, et al.
Publicado: (2017)

Ertapenem rescue therapy in hidradenitis suppurativa
por: Chahine, Adam A., et al.
Publicado: (2018)

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022)

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
por: Gulliver, Wayne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5p9i9d7pdlpqp0u6bvib3ivfhn